Identification of molecular determinants that regulate tumor progression would help in improving diagnosis and prognosis for cancer patients. Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan that promotes tumor metastasis. Hyaluronidase (HAase) is an endoglycosidase that degrades HA into small angiogenic fragments. In an earlier study we demonstrated that measurement of urinary levels of HA and HAase (HA-HAase test) is > 90% accurate in detecting bladder cancer (BCa) and evaluating its grade. In this study, we examined the ability of the HA-HAase test to monitor patients for BCa recurrence and examined the effect of HA fragments, isolated from patient samples, on endothelial cell functions.
